Skip to main content
Erschienen in: Rheumatology International 3/2013

01.03.2013 | Original Article

Carpal tunnel syndrome and metabolic syndrome co-occurrence

verfasst von: Burcu Önder, Elif Yalçın, Barın Selçuk, Aydan Kurtaran, Müfit Akyüz

Erschienen in: Rheumatology International | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

We aimed to evaluate the relation between the severity of carpal tunnel syndrome and metabolic syndrome. One hundred and fifty patients who had a clinical and electrophysiologically confirmed diagnosis of carpal tunnel syndrome (CTS), were included in this study. The patients were divided into two groups (with or without metabolic syndrome) according to the criteria of National Cholesterol Education Program. Eighty one (73.5 %) of the patients with CTS had metabolic syndrome. The patients with metabolic syndrome the severity of CTS was found 22.2 % had mild CTS, 56.8 % had moderate CTS, and 21 % had severe CTS. The patients without metabolic syndrome the severity of CTS was found 44.9 % had mild CTS, 40.6 % had moderate CTS, and 14.5 % had severe CTS. The severity of CTS between both groups was found to be statistically significant (p = 0.0009). While a correlation was found between the severity of CTS and high level of LDL with the presence of metabolic syndrome (correlation coefficient 0.209). In conclusion metabolic syndrome that appears to be a risk factor for CTS. At the same time, the presence of metabolic syndrome increases the severity of the disease.
Literatur
1.
Zurück zum Zitat Boulton AJ, Malik RA, Arezzo JC, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27(6):1458–1486PubMedCrossRef Boulton AJ, Malik RA, Arezzo JC, Sosenko JM (2004) Diabetic somatic neuropathies. Diabetes Care 27(6):1458–1486PubMedCrossRef
2.
Zurück zum Zitat Preston DC, Shapiro BE (2005) Electromyography and neuromuscular disorders. Clinical-electrophysiologic correlations. In: Preston DC, Shapiro BE (eds) Median neuropathy at the wrist, 2nd edn. Elsevier, Philadelphia, pp 255–281 Preston DC, Shapiro BE (2005) Electromyography and neuromuscular disorders. Clinical-electrophysiologic correlations. In: Preston DC, Shapiro BE (eds) Median neuropathy at the wrist, 2nd edn. Elsevier, Philadelphia, pp 255–281
3.
Zurück zum Zitat Balcı K, Utku U (2007) Carpal tunnel syndrome and metabolic syndrome. Acta Neurol Scand 116:113–117PubMed Balcı K, Utku U (2007) Carpal tunnel syndrome and metabolic syndrome. Acta Neurol Scand 116:113–117PubMed
4.
Zurück zum Zitat American Academy of Neurology (1993) Practice parameter for carpal tunnel syndrome. Report of Quality Standards Subcommittee of the American Academy of Neurology. Neurology 43:2406–2409CrossRef American Academy of Neurology (1993) Practice parameter for carpal tunnel syndrome. Report of Quality Standards Subcommittee of the American Academy of Neurology. Neurology 43:2406–2409CrossRef
5.
Zurück zum Zitat Grant RW, Meigs JB (2005) Management of the metabolic syndrome. Panminerva Med.üğ 47(4):219–228 Grant RW, Meigs JB (2005) Management of the metabolic syndrome. Panminerva Med.üğ 47(4):219–228
6.
Zurück zum Zitat Bloomgarden ZT (2003) American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome:25–26 August 2002, Washington, DC. Diabetes Care 26:1297–1303PubMedCrossRef Bloomgarden ZT (2003) American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome:25–26 August 2002, Washington, DC. Diabetes Care 26:1297–1303PubMedCrossRef
7.
Zurück zum Zitat Padua L, LoMonaco M, Gregori B, Valente EM, Padua R, Tonali P (1997) Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome. Acta Neurol Scand 96(4):211–217PubMedCrossRef Padua L, LoMonaco M, Gregori B, Valente EM, Padua R, Tonali P (1997) Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome. Acta Neurol Scand 96(4):211–217PubMedCrossRef
9.
Zurück zum Zitat De Krom MC, Knipschild PG, Kester AD, Thijs CT, Boekkooi PF, Spaans F (1992) Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol 45(4):373–376PubMedCrossRef De Krom MC, Knipschild PG, Kester AD, Thijs CT, Boekkooi PF, Spaans F (1992) Carpal tunnel syndrome: prevalence in the general population. J Clin Epidemiol 45(4):373–376PubMedCrossRef
10.
Zurück zum Zitat Lewis C, Mauffrey C, Newman S, Lambert A, Hull P (2010) Current concepts in carpal tunnel syndrome: a review of the literature. Eur J Orthop Surg Traumatol 20:445–452CrossRef Lewis C, Mauffrey C, Newman S, Lambert A, Hull P (2010) Current concepts in carpal tunnel syndrome: a review of the literature. Eur J Orthop Surg Traumatol 20:445–452CrossRef
11.
Zurück zum Zitat MacDermid JC, Wessel J (2004) Clinical diagnosis of carpal tunnel syndrome: a systematic review. J Hand Ther 17(2):309–319PubMedCrossRef MacDermid JC, Wessel J (2004) Clinical diagnosis of carpal tunnel syndrome: a systematic review. J Hand Ther 17(2):309–319PubMedCrossRef
12.
Zurück zum Zitat Kaymak B, Ozçakar L, Cetin A, Candan Cetin M, Akinci A, Hasçelik Z (2008) A comparison of the benefits of sonography and electrophysiologic measurements as predictors of symptom severity and functional status in patients with carpal tunnel syndrome. Arch Phys Med Rehabil 89(4):743–748PubMedCrossRef Kaymak B, Ozçakar L, Cetin A, Candan Cetin M, Akinci A, Hasçelik Z (2008) A comparison of the benefits of sonography and electrophysiologic measurements as predictors of symptom severity and functional status in patients with carpal tunnel syndrome. Arch Phys Med Rehabil 89(4):743–748PubMedCrossRef
13.
Zurück zum Zitat Deryani E, Aki S, Muslumanoglu L, Rozanes I (2003) MR imaging and electrophysiological evaluation in carpal tunnel syndrome. Yonsei Med J 44(1):27–32PubMed Deryani E, Aki S, Muslumanoglu L, Rozanes I (2003) MR imaging and electrophysiological evaluation in carpal tunnel syndrome. Yonsei Med J 44(1):27–32PubMed
14.
Zurück zum Zitat Becker J, Nora DB, Gomes I, Stringari FF, Seitensus R, Panosso JS, Ehlers JC (2002) An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 113(9):1429–1434PubMedCrossRef Becker J, Nora DB, Gomes I, Stringari FF, Seitensus R, Panosso JS, Ehlers JC (2002) An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 113(9):1429–1434PubMedCrossRef
15.
Zurück zum Zitat Hooper MM (2006) Tending to the musculoskeletal problems of obesity. Clevel Clin J Med 73(9):839–845CrossRef Hooper MM (2006) Tending to the musculoskeletal problems of obesity. Clevel Clin J Med 73(9):839–845CrossRef
16.
Zurück zum Zitat Nordstrom DL, Vierkant RA, DeStefano F, Layde PM (1997) Risk factors for carpal tunnel syndrome in a general population. Occup Environ Med 54(10):734–740PubMedCrossRef Nordstrom DL, Vierkant RA, DeStefano F, Layde PM (1997) Risk factors for carpal tunnel syndrome in a general population. Occup Environ Med 54(10):734–740PubMedCrossRef
17.
Zurück zum Zitat Werner RA, Albers JW, Franzblau A, Armstrong TJ (1994) The relationship between body mass index and the diagnosis of carpal tunnel syndrome. Muscle Nerve 17(6):632–636PubMedCrossRef Werner RA, Albers JW, Franzblau A, Armstrong TJ (1994) The relationship between body mass index and the diagnosis of carpal tunnel syndrome. Muscle Nerve 17(6):632–636PubMedCrossRef
18.
Zurück zum Zitat Becker J, Nora DB, Gomes I, Stringari FF, Seitensus R, Panosso JS, Ehlers JC (2002) An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 113(9):1429–1434PubMedCrossRef Becker J, Nora DB, Gomes I, Stringari FF, Seitensus R, Panosso JS, Ehlers JC (2002) An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 113(9):1429–1434PubMedCrossRef
19.
Zurück zum Zitat Oğuz A, Temizhan A, Abaci A, Kozan O, Erol C, Ongen Z, Celik S (2008) Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults. Anadolu Kardiyol Derg 8(6):401–406PubMed Oğuz A, Temizhan A, Abaci A, Kozan O, Erol C, Ongen Z, Celik S (2008) Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults. Anadolu Kardiyol Derg 8(6):401–406PubMed
20.
Zurück zum Zitat Geoghegan JM, Clark DI, Bainbridge LC, Smith C, Hubbard R (2004) Risk factors in carpal tunnel syndrome. J Hand Surg Br 29(4):315–320PubMedCrossRef Geoghegan JM, Clark DI, Bainbridge LC, Smith C, Hubbard R (2004) Risk factors in carpal tunnel syndrome. J Hand Surg Br 29(4):315–320PubMedCrossRef
21.
Zurück zum Zitat Perkins BA, Olaleve D, Bril V (2002) Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 25(3):565–569PubMedCrossRef Perkins BA, Olaleve D, Bril V (2002) Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 25(3):565–569PubMedCrossRef
22.
Zurück zum Zitat Nakamichi K, Tachibana S (2005) Hypercholesterolemia as a risk factor for idiopathic carpal tunnel syndrome. Muscle Nerve 32(3):364–367PubMedCrossRef Nakamichi K, Tachibana S (2005) Hypercholesterolemia as a risk factor for idiopathic carpal tunnel syndrome. Muscle Nerve 32(3):364–367PubMedCrossRef
23.
Zurück zum Zitat Satman I, Yılmaz T, Sengul A, Salman S, Salman F, Uygur S, Bastar I, Tütüncü Y, Sargın M, Dinççağ N, Karsidag K, Kalaça S, Özcan C, King H, the TURDEP Group (2002) Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25:1551–1556PubMedCrossRef Satman I, Yılmaz T, Sengul A, Salman S, Salman F, Uygur S, Bastar I, Tütüncü Y, Sargın M, Dinççağ N, Karsidag K, Kalaça S, Özcan C, King H, the TURDEP Group (2002) Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 25:1551–1556PubMedCrossRef
24.
Zurück zum Zitat Freeland AE, Tucci MA, Barbieri RA, Angel MF, Nick TG (2002) Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery 22(8):378–385PubMedCrossRef Freeland AE, Tucci MA, Barbieri RA, Angel MF, Nick TG (2002) Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery 22(8):378–385PubMedCrossRef
25.
Zurück zum Zitat Koh KK, Han SH, Quon MJ (2005) Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 46(11):1978–1985PubMedCrossRef Koh KK, Han SH, Quon MJ (2005) Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions. J Am Coll Cardiol 46(11):1978–1985PubMedCrossRef
Metadaten
Titel
Carpal tunnel syndrome and metabolic syndrome co-occurrence
verfasst von
Burcu Önder
Elif Yalçın
Barın Selçuk
Aydan Kurtaran
Müfit Akyüz
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 3/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2417-1

Weitere Artikel der Ausgabe 3/2013

Rheumatology International 3/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.